-Anuska Sen, Team bioXone
On 10th September 2020, that is 2 days back, Team BioXone had covered a piece of news stating the pause of the Covid-19 vaccine of AstraZeneca by Serum Institute.
Today, it has been reported that once again, the trials for AstraZeneca’s Covid-19 vaccine has been successfully resumed. The one reason that the trials had been put on hold was an unexplained illness of one of the volunteers on whom the vaccine was administered.
AstraZeneca has confirmed that they have resumed their trials in the UK as it has been confirmed by different medical tests that the illness of the patient was not at all due to the administration of the vaccine and neither was it in any way related to the effects of the vaccine. A special committee was created to investigate the safety and other medical issues in the latest case, which has reported that the vaccine trials can be resumed safely in the UK.
However, as AstraZeneca says that it has never compromised with the safety of the trial volunteers and the level of conduct in its clinical trials, the trials had been “voluntarily” paused for high standard security purposes. Now that it has no other barriers in its way till now, as confirmed by Medicines Health Regulatory Authority (MHRA), the trials will be resumed soon.
Genetic engineering- a potential weapon to kill?
–Ayooshi Mitra, Amity University Kolkata With the horror with which Covid-19 is spreading presently, the story of U.S President Donald Trump’s suggestion that the Coronavirus was either engineered intentionally or was the result of a laboratory accident at the Wuhan Institute of Virology in China, has brought forward terror in the minds of people. According […]